Primary Record
LOSARTAN POTASSIUM
- In stock
- 4,137 g
- Purity
- 98.6 %
- CAS
- 124750-99-8
Compound Identifiers & Properties
- CAS
- 124750-99-8
- PubChem CID
- 11751549
- SMILES
- CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+]
- Canonical SMILES
- CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[n-]2)cc1.[K+]
Names & Synonyms
- LOSARTAN POTASSIUM
- Cozaar
- Losacar
- Losaprex
- Losata
- Tancin
- Aradois
- Lorzaar
- Hyzaar
- Zaart
- Nu-Lotan
- Tenopres
- Lifezar
- Lortaan
- Lorzaan
- Losacor
- 124750-99-8
- Ocsaar
- Lotim
- Niten
- ERYTHROPOIETIN
- losartan potassium salt
- Presartan-50
- Neo Lotan
- Covance
- losartanpotassium
- Losartan Base
- Losartanpatassium
- Losatan Potassium
- Losortan Potassium
- Losartan Potatssium
- Losartan monopotassium salt
- Losartan Potassium?
- Potassium, Losartan
- Cozaar (TN)
- ARBLI
- Du Pont 753
- Losartan Potassium RS
- DuP 753
- DuP-753
- DuP753
- Losartan potassium CRS
- RefChem:55520
- DU PONT-753
- Losartan potassium [USAN]
- losartan potassium tablet
- Losartan Potassium (DuP 753)
- MK-0954
- MK0954
- CHEMBL995
- UNII-3ST302B24A
- C22H22CIKN6OK
- 3ST302B24A
- Monopotassium Salt, Losartan
- Salt, Losartan Monopotassium
- C22H23ClN6O.K
- Losartan potassium [USAN:USP]
- MK 954
- SCHEMBL42079
- DTXSID3044209
- MLS001401407
- Ex-89
- orb1310826
- DTXCID1024209
- LOSARTAN POTASSIUM [JAN]
- LOSARTAN POTASSIUM 25 mg
- LOSARTAN POTASSIUM 50 mg
- CTK8B3241
- HSDB 7043
- Losartan potassium (JP18/USP)
- LOSARTAN POTASSIUM [HSDB]
- LOSARTAN POTASSIUM 100 mg
- MFCD02092704
- MK-954
- C22-H23-Cl-N6-O.K
- HMS2051M12
- HMS2090O22
- HMS2235F20
- HMS3369F08
- HMS3393M12
- Losartan Potassium (1370462)
- LOSARTAN POTASSIUM [VANDF]
- L-158086
- LOSARTAN POTASSIUM [MART.]
- ACT02618
- BCP05332
- BCP29397
- CID60771
- LOSARTAN POTASSIUM [USP-RS]
- LOSARTAN POTASSIUM [WHO-DD]
- Losartan Potassium Tablets, 25 mg
- Losartan Potassium Tablets, 50 mg
- MK 0954
- MSK10415
- ANW-42060
- E-3340
- Losartan Potassium Tablets, 100 mg
- AKOS015955543
- AKOS025310168
- AC-1072
- ACN-036719
- CCG-100869
- CS-O-01767
- FL24945
- Losartan potassium - Bio-X trade mark
- Losartan potassium, analytical standard
- NC00119
- RTR-003798
- CID11751549
- LOSARTAN MONOPOTASSIUM SALT [MI]
- LOSARTAN POTASSIUM [ORANGE BOOK]
- LOSARTAN POTASSIUM [EP MONOGRAPH]
- AN-15300
- BL164642
- CPD000469593
- HYZAAR COMPONENT LOSARTAN POTASSIUM
- LOSARTAN POTASSIUM [USP MONOGRAPH]
- SAM001246635
- SMR000469593
- AB0072997
- AB2000067
- TR-003798
- A1425
- FT-0627982
- L-185
- L0232
- NS00076270
- ST24047507
- 124750-99-8 (Ka+)
- J1.865.242K
- D00357
- J10063
- 11096-26-7
- AB01275507-01
- 750L998
- A805291
- SR-05000001514
- SR-05000001514-1
- Q27257991
- 2-Butyl-4-chloro-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)imidazole-5-methanol, monopotassium salt
- B0046-464141
- potassium 5-(4'-((2-butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-yl)tetrazol-1-ide
- potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
- 2-Butyl-4-chloro-1-(2'-(tetrazol-5-yl)biphenyl-4-ylmethyl)-1H-imidazole-5-methanol potassium
- Losartan Potassium Working Standard (Secondary Reference Standard)
- Losartan potassium, European Pharmacopoeia (EP) Reference Standard
- 2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl]imidazole-5-methanol Potassium Salt
- 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol, monopotassium salt
- Losartan Potassium is known as a potent, synthetic AT1 receptor antagonist.
- Losartan potassium, United States Pharmacopeia (USP) Reference Standard
- Losartan Potassium, Pharmaceutical Secondary Standard; Certified Reference Material
- (1-((2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methanol, potassium salt
- (2-butyl-4-chloro-1-{[2'-(1-potassio-1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methanol
- 1H-imidazol-5-metanol, 2-butil-4-cloro-1-[[2'-(2H-tetrazol-5-il) [1,1'-bifenilo]] metil]-4-il-, potasio sal (1:1)
- 1H-Imidazole-5-methanol 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[11'-biphenyl]-4-yl]methyl]-monopotassium salt (9CI)
- 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, monopotassium salt
- 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-((2-(1H-tetrazol-5-yl)(1,1-biphenyl)-4-yl)methyl)-, monopotassium salt
- 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, monopotassium salt
- 1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, potassium salt (1:1)
- 2-Butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol, Monopotassium Salt
- 2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol potassium
- 2-Butyl-4-chloro-1-[2 -(1-potassio-1H-tetrazole-5-yl)-4-biphenylylmethyl]-1H-imidazole-5-methanol
- 2-Butyl-4-chloro-1-{[2 inverted exclamation marka-(1H-tetrazol-5-yl)(1,1 inverted exclamation marka-biphenyl)-4-yl]methyl}-1H-imidazole-5-methanol monopotassium salt
- 658-044-7
- EPO
- Losartan potassium; Potassium 5-[4'-[[2-butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl]methyl]biphenyl-2-yl]tetrazol-1-ide
- Monopotassium 5-((4'-(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl)biphenyl-2-yl)-1H-tetrazol-1-ide
- potassium [2-butyl-5-chloro-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
- Potassium 5-(4'-{[2-butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl]methyl}[1,1'-biphenyl]-2-yl)tetrazol-1-ide
- potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol.